Co. – Diagnostics, Inc.
$1.85 -$0.25 (-11.91%) 1D Market openKey Metrics
The Story So Far
LAST 6 MONTHS PRIMARY SOURCES ONLY-
Jul 27
A material event was filed (Form 8-K).
8-K - Co-Diagnostics, Inc. (0001692415) (Filer)
RECEIPT: SEC FORM 8-K, TIMESTAMPED -
Jul 27
Offering paper hit the record (Form 424B5).
424B5 - Co-Diagnostics, Inc. (0001692415) (Filer)
RECEIPT: SEC FORM 424B5, TIMESTAMPED -
Jul 27
An insider transaction hit the record.
Form 4s are events, not verdicts — officers, directors, and 10% owners reporting their own trades. The forms post hours before the media writes them up.
RECEIPT: SEC FORM 4, TIMESTAMPED -
Jul 27
From its May 28 high, the share price fell 82%.
Peak close $11.19 on May 28; trough close $2.04 on Jul 27. The drawdown is the fact — the chapters around it are the context.
RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -82% -
Jul 16
Money rotated out of high-beta cohorts market-wide.
High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.
RECEIPT: ROTATION GAUGE, LIVE -
May 26
The stock moved +79.7% in a single session.
Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.
RECEIPT: DAILY BAR, May 26 -
Mar 10
The stock moved +101.8% in a single session.
Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.
RECEIPT: DAILY BAR, Mar 10
The story updates itself as events post · The wolf reports; you decide
Snapshot
About Co. – Diagnostics, Inc.
Co-Diagnostics Inc is a molecular diagnostics company.
Wolf Grade COMING SOON
The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.